Form 4: Blade Air Mobility Executive Receives Stock Grants
SEC Form 4
Seth J. Bacon, CEO of Trinity Air Medical (a subsidiary of Blade Air Mobility), received stock grants in the form of Restricted Stock Units (RSUs).
Summary
- Seth J. Bacon, CEO of Trinity Air Medical, a subsidiary of Blade Air Mobility, received a grant of 260,035 Class A common stock RSUs on March 8, 2024.
- These RSUs will vest in three tranches: December 8, 2024, December 8, 2025, and December 8, 2026, subject to continued service.
- Bacon also directly owns 344,832 shares of Class A common stock and indirectly owns 1,010,767 shares through JB3 Holdings, LLC, where he is the sole member.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. It reflects a standard executive compensation practice, which is generally viewed as a positive sign of incentivizing management.
Positives
- The grant of RSUs to a key executive like Seth J. Bacon could be seen as an incentive to drive future performance and align his interests with those of the shareholders.
Future Outlook
The document does not contain specific forward-looking statements, but the vesting schedule of the RSUs suggests a multi-year commitment from the executive.
Industry Context
This type of stock grant is a common practice in the industry to incentivize and retain key executives. The vesting schedule is typical for such grants.
Comparison to Industry Standards
- Stock grants and RSU awards are standard compensation practices for executives in publicly traded companies, particularly in growth-oriented sectors like air mobility.
- Vesting schedules of three years are common to ensure long-term commitment and alignment with shareholder value creation.
- Comparable companies in the air mobility or technology sectors often use similar equity-based compensation packages to attract and retain talent.
Stakeholder Impact
- Shareholders may view the RSU grant as a positive incentive for the executive to drive company performance.
- Employees may see this as a sign of stability and commitment from the leadership team.
Key Dates
| Date | Description |
|---|---|
| 03/08/2024 | Date of transaction: Grant of 260,035 RSUs and acquisition of 676,029 shares. |
| 12/08/2024 | First vesting date for 33.3% of the RSUs. |
| 12/08/2025 | Second vesting date for 33.3% of the RSUs. |
| 12/08/2026 | Final vesting date for the remaining RSUs. |
| 03/12/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.